A case of anti-myelin oligodendrocyte glycoprotein (MOG) antibody-related disease with human leukocyte antigen (HLA) positivity indicative of neuro-Sweet disease-Reference-Cited by-同舟云学术

A case of anti-myelin oligodendrocyte glycoprotein (MOG) antibody-related disease with human leukocyte antigen (HLA) positivity indicative of neuro-Sweet disease

Published:2020 Issue:1 Volume:60 Page:51-56
ISSN:0009-918X
Container-title:Rinsho Shinkeigaku
language:en
Short-container-title:Rinsho Shinkeigaku

Author:

Takeuchi Yosuke¹²,Kouzaki Yanosuke¹

Affiliation:

1. Department of Neurology, National Hospital Organization Kumamoto Medical Center

2. Department of Neurology, National Hospital Organization Kumamotominami National Hospital

Publisher

Societas Neurologica Japonica

Subject

Clinical Neurology

Link

https://www.jstage.jst.go.jp/article/clinicalneurol/60/1/60_cn-001360/_pdf

Reference17 articles.

1. 1) Reindl M, Pauli F, Rostásy K, et al. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 2013;9:455-461.

2. 2) Cobo-Calvo Á, Sepúlveda M, Bernard-Valnet R, et al. Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications. Mult Scler 2016;22:312-319.

3. 3) Fujimori J, Takai Y, Nakashima I, et al. Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies. J Neurol Neurosurg Psychiatry 2017;88:534-536.

4. 4) Fukushima N, Suzuki M, Ogawa R, et al. A case of anti-MOG antibody-positive multiphasic disseminated encephalomyelitis co-occurring with unilateral cerebral cortical encephalitis. Clin Neurol 2017;57:723-728.

5. 5) Hisanaga K, Iwasaki Y, Itoyama Y, et al. Neuro-Sweet disease: Clinical manifestations and criteria for diagnosis. Neurology 2005;64:1756-1761.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-MOG antibodies associated demyelination following encephalomeningitis: Case report;Journal of Neuroimmunology;2021-04